Pacific Biosciences Of California (PACB) Amortization - Intangibles (2021 - 2026)
Pacific Biosciences Of California's quarterly Amortization - Intangibles came in at $183000.0 in Q1 2026, down 99.95% year-on-year from $362.0 million in Q1 2025, and up 100.05% quarter-over-quarter from -$358.8 million in Q4 2025.
Pacific Biosciences Of California has reported Amortization - Intangibles for 6 years, with the latest figure at $183000.0 in Q1 2026.
- For the quarter ending Q1 2026, Amortization - Intangibles fell 99.95% year-over-year to $183000.0; the trailing twelve-month figure through Mar 2026 stood at -$357.0 million (down 195.83% YoY), and the FY2025 full-year result was $4.9 million, down 72.82% from the prior year.
- Amortization - Intangibles for Q1 2026 stood at $183000.0, up from -$358.8 million in the prior quarter.
- The five-year high for Amortization - Intangibles was $362.0 million in Q1 2025, with the low at -$358.8 million in Q4 2025.
- Average Amortization - Intangibles over 5 years is $2.0 million, with a median of $833000.0 recorded in 2025.
- Peak annual rise in Amortization - Intangibles reached 6475.41% in 2025, while the deepest fall reached 7851.44% in 2025.
- Tracing PACB's Amortization - Intangibles over 5 years: stood at $733000.0 in 2022, then soared by 638.88% to $5.4 million in 2023, then dropped by 14.53% to $4.6 million in 2024, then slumped by 7851.44% to -$358.8 million in 2025, then surged by 100.05% to $183000.0 in 2026.
- The last three Amortization - Intangibles figures came in at $183000.0 (Q1 2026), -$358.8 million (Q4 2025), and $833000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Pacific Biosciences Of California | 481.66 Mn | 205.70 Mn | 12.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | -358.81 Mn |
| Sep 30, 2025 | 833,000.00 |
| Jun 30, 2025 | 833,000.00 |
| Mar 31, 2025 | 362.04 Mn |
| Dec 31, 2024 | 4.63 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 2.63 Mn |
| Mar 31, 2024 | 5.51 Mn |
| Dec 31, 2023 | 5.42 Mn |
| Sep 30, 2023 | 741,000.00 |
| Dec 31, 2022 | 733,000.00 |
| Jun 30, 2022 | 183,000.00 |
| Mar 31, 2022 | 183,000.00 |
| Dec 31, 2021 | -123,000.00 |